| Literature DB >> 35195337 |
Tuija Hautakangas1,2, Jukka Uotila3, Joel Kontiainen2, Heini Huhtala4, Outi Palomäki3.
Abstract
Entities:
Keywords: Montevideo unit; body mass index; caesarean section; contraction; dystociainduction of labour; intrauterine pressure; intrauterine pressure catheter; mode of delivery; obesity; oxytocin
Mesh:
Substances:
Year: 2022 PMID: 35195337 PMCID: PMC9545745 DOI: 10.1111/1471-0528.17128
Source DB: PubMed Journal: BJOG ISSN: 1470-0328 Impact factor: 7.331
Figure 1Intrauterine pressure and use of oxytocin at different time points during the last 4 hours before vaginal birth or before a decision on caesarean section, with a BMI limit of 35 kg/m2; blue line <35 kg/m2, red line ≥35 kg/m2
Characteristics of the study population, with BMI limit of 35 kg/m2
|
BMI <35 kg/m2
|
BMI ≥35 kg/m2
|
| |||
|---|---|---|---|---|---|
|
| %/Q1–Q3 |
| %/Q1–Q3 | ||
| At least one previous vaginal delivery | 132 | 22 | 20 | 24 | 0.697 |
| Maternal age (years) | 30.0 | 26–33 | 29.0 | 24–33 | 0.135 |
| Maternal height (metres) | 1.65 | 1.62–1.70 | 1.65 | 0.06/1.60–1.70 | 0.810 |
| Gestational age (days) | 282 | 275–288 | 280 | 273–288 | 0.144 |
| Pregestational or gestational diabetes | 135 | 22.4 | 52 | 61.9 | <0.001 |
| Induction of labour | 333 | 55 | 72 | 86 | <0.001 |
| Prostaglandin E2 and/or Foley catheter | 146 | 24 | 38 | 45 | <0.001 |
| Prostaglandin E2 | 101 | 17 | 31 | 37 | <0.001 |
| Foley catheter | 75 | 12 | 15 | 18 | 0.170 |
| Amniotomy and/or oxytocin | 186 | 31 | 34 | 40 | 0.078 |
| Cervical dilatation at recruitment | 3.5 | 3.0–4.0 | 3.0 | 3.0–4.0 | 0.231 |
BMI, body mass index, kg/m2; SD, standard deviation.
More than one method per patient was used when needed.
Uterine contractile activity and the use of oxytocin during the last 4 hours of labour, with BMI limit of 35 kg/m2
|
BMI <35 kg/m2
|
BMI ≥35 kg/m2
|
| |||
|---|---|---|---|---|---|
|
| %/Q1–Q3 |
| %/ Q1–Q3 | ||
| Intrauterine pressure, MVU | |||||
| ≥200, | |||||
| All parturients | 297 | 49 | 52 | 61 | 0.031 |
| No previous VD | 249 | 53 | 43 | 67 | 0.032 |
| Previous VD | 48 | 36 | 9 | 45 | 0.457 |
| Highest | |||||
| All parturients | 190 | 144–240 | 222 | 155–263 | 0.120 |
| Spontaneous onset of labour | 200 | 150–250 | 194 | 125–278 | 0.997 |
| Induction of labour | 190 | 147–240 | 220 | 152–263 | 0.071 |
| No previous VD | 200 | 150–250 | 226 | 170–278 | 0.039 |
| Previous VD | 170 | 120–210 | 165 | 103–228 | 0.812 |
| Spontaneous vaginal delivery | 190 | 140–240 | 205 | 135–260 | 0.597 |
| Vacuum extraction | 225 | 170–288 | 230 | 218–343 | 0.226 |
| Caesarean section | 177 | 130–220 | 214 | 133–260 | 0.075 |
| Frequency/10 min, maximum | |||||
| All parturients | 4.7 | 4.0–5.0 | 5.0 | 4.0–5.0 | 0.432 |
| Basal tonus of uterine muscle, mmHg | |||||
| Maximum | |||||
| All parturients | 20 | 20–25 | 25 | 20–30 | <0.001 |
| No previous VD | 20 | 20–30 | 25 | 20–30 | 0.001 |
| Previous VD | 20 | 15–20 | 20 | 20–25 | 0.033 |
| Use of oxytocin | |||||
| Use during stage I, | 569 | 95 | 83 | 99 | 0.108 |
| Dose >15 mIU/min during stage I, | 145 | 24 | 24 | 29 | 0.371 |
| Total consumption, IU, all parturients | 3.0 | 1.5–5.0 | 3.2 | 2.0–5.5 | 0.296 |
| No previous VD | 3.0 | 1.5–5.0 | 4.0 | 2.0–6.0 | 0.111 |
| Maximum dose, mIU/min, stage I | |||||
| All parturients | 10.0 | 5.0–15.0 | 10.0 | 5.0–15.0 | 0.098 |
| No previous VD | 10.0 | 5.0–10.0 | 11.3 | 5.0–17.5 | 0.051 |
| Present delivery VD | 7.5 | 4.0–12.5 | 7.5 | 5.0–12.5 | 0.549 |
| Present delivery CS | 12.5 | 5.0–17.5 | 12.5 | 9.5–20.4 | 0.126 |
| Mean dose, mIU/min, stage I, all parturients | 6.0 | 2.5–10.8 | 6.9 | 3.1–12.5 | 0.158 |
| No previous VD | 5.9 | 2.3–11.3 | 8.8 | 3.1–14.4 | 0.078 |
| Present delivery VD | 5.0 | 1.9–9.4 | 5.3 | 2.3–10.8 | 0.528 |
| Present delivery CS | 8.1 | 3.1–14.1 | 9.6 | 5.7–14.4 | 0.293 |
BMI, body mass index; CS, caesarean section; Q, quartile; MVU, Montevideo unit; VD, vaginal delivery.
BMI limit of 35 kg/m2 and its association with labour outcomes
|
BMI <35 kg/m2
|
BMI ≥35 kg/m2
| OR | 95% CI |
| |||
|---|---|---|---|---|---|---|---|
|
| %/SD/Q1–Q3 |
| %/ SD/Q1–Q3 | ||||
| Cervical dilatation 10 cm not reached | 108 | 18 | 24 | 29 | 1.81 | 1.09–3.03 | 0.021 |
| Active stage of labour not reached, i.e. cervical dilatation ≥6 cm | 55 | 10 | 16 | 20 | 2.36 | 1.28–4.37 | 0.005 |
| Caesarean section | 119 | 20 | 26 | 31 | 1.82 | 1.10–3.01 | 0.019 |
| No previous VD | 108 | 23 | 23 | 36 | 1.88 | 1.08–3.27 | 0.024 |
| Previous VD | 11 | 8 | 2 | 10 | 1.22 | 0.25–5.97 | 0.804 |
| Indication of CS | |||||||
| Dystocia, failed IOL excluded | 66 | 11 | 10 | 12 | 1.10 | 0.54–2.23 | 0.797 |
| Failed IOL | 18 | 3 | 10 | 12 | 4.38 | 1.95–9.86 | 0.001 |
| Fetal distress | 38 | 6 | 7 | 8 | 1.35 | 0.58–3.13 | 0.483 |
| Vacuum extraction | 92 | 15 | 10 | 12 | 0.75 | 0.37–1.50 | 0.415 |
| Chorioamnionitis | 68 | 11 | 18 | 21 | 2.14 | 1.20–3.82 | 0.009 |
| Birthweight >4 kg | 151 | 25 | 23 | 27 | 1.13 | 0.67–1.88 | 0.650 |
| Composite adverse neonatal outcome | 77 | 13 | 6 | 7 | 0.52 | 0.22–1.25 | 0.137 |
BMI, body mass index; CS, caesarean section; IOL, induction of labour; VD, vaginal delivery.
32 missing values, 28 (4.7%) in BMI group <35 kg/m2 and 4 (4.8%) in BMI group ≥35 kg/m2.
Intrapartum temperature more than 38.0°C or a combination of fetal tachycardia and maternal C‐reactive protein more than 20 g/L.